Managed Healthcare Executive

What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation

Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...
BMJ Evidence-Based Medicine

Current knowledge on the adaptation of clinical practice guidelines: a scoping review

Background The adaptation of clinical practice guidelines (CPGs) is increasingly used to efficiently develop contextualised ...
WRAL

Quintiles Forms Unit To Help Clients Adapt Clinical Trials

, a contract research organization for the life science industry, has formed a unit to help clients conducting clinical trials. The Strategic Biostatistics Unit will focus on "adaptive design" and ...
STAT

Development of clinical practice guidelines ‘is a mess’

The world of clinical practice guidelines is a mess. Regardless of what medical field you look at — oncology, cardiology, urology — looking at guidelines recommending treatment developed for different ...
TMCnet

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...
CNN

Spero Therapeutics Completes Patient Enrollment in Pivotal Phase 3 Clinical Trial (ADAPT-PO) of Oral Tebipenem HBr versus Intravenous Ertapenem for the Treatment of Complicated ...

CAMBRIDGE, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...